Gwyn Bebb

1.5k total citations · 1 hit paper
48 papers, 1.1k citations indexed

About

Gwyn Bebb is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Gwyn Bebb has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Gwyn Bebb's work include Lung Cancer Treatments and Mutations (16 papers), DNA Repair Mechanisms (6 papers) and Lung Cancer Research Studies (6 papers). Gwyn Bebb is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), DNA Repair Mechanisms (6 papers) and Lung Cancer Research Studies (6 papers). Gwyn Bebb collaborates with scholars based in Canada, United States and United Kingdom. Gwyn Bebb's co-authors include Cheryl Ho, Nevin Murray, Christian Kollmannsberger, Normand Blais, Michael Smylie, Nancy Nixon, Randy D. Gascoyne, Scott Ernst, Sunil Verma and Marcus O. Butler and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gwyn Bebb

47 papers receiving 1.1k citations

Hit Papers

Emerging therapies targeting the delta-like ligand 3 (DLL... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gwyn Bebb Canada 20 643 360 311 157 133 48 1.1k
Véronique D’Hondt France 21 781 1.2× 298 0.8× 335 1.1× 241 1.5× 102 0.8× 83 1.3k
Vincenzo Sforza Italy 18 680 1.1× 380 1.1× 362 1.2× 194 1.2× 173 1.3× 58 1.2k
Thomas Makatsoris Greece 22 1.0k 1.6× 362 1.0× 338 1.1× 198 1.3× 135 1.0× 85 1.5k
Salvatore Lopez Italy 25 551 0.9× 369 1.0× 213 0.7× 183 1.2× 117 0.9× 89 1.6k
Patrizia Serra Italy 19 593 0.9× 277 0.8× 261 0.8× 244 1.6× 78 0.6× 51 1.0k
Roberta Maltoni Italy 21 722 1.1× 338 0.9× 299 1.0× 376 2.4× 99 0.7× 84 1.2k
Pedro Pérez‐Segura Spain 18 467 0.7× 407 1.1× 237 0.8× 294 1.9× 196 1.5× 117 1.2k
Adrian Langleben Canada 17 725 1.1× 316 0.9× 416 1.3× 158 1.0× 63 0.5× 55 1.1k
Laure Favier France 16 573 0.9× 328 0.9× 197 0.6× 172 1.1× 63 0.5× 61 1.0k
Jacques Raphael Canada 15 541 0.8× 187 0.5× 315 1.0× 167 1.1× 58 0.4× 70 1.1k

Countries citing papers authored by Gwyn Bebb

Since Specialization
Citations

This map shows the geographic impact of Gwyn Bebb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gwyn Bebb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gwyn Bebb more than expected).

Fields of papers citing papers by Gwyn Bebb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gwyn Bebb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gwyn Bebb. The network helps show where Gwyn Bebb may publish in the future.

Co-authorship network of co-authors of Gwyn Bebb

This figure shows the co-authorship network connecting the top 25 collaborators of Gwyn Bebb. A scholar is included among the top collaborators of Gwyn Bebb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gwyn Bebb. Gwyn Bebb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bylsma, Lauren C., Xerxes Pundole, Chia‐Hsin Ju, et al.. (2023). Systematic Literature Review of the Prevalence and Prognostic Value of Delta-Like Ligand 3 Protein Expression in Small Cell Lung Cancer. Targeted Oncology. 18(6). 821–835. 2 indexed citations
2.
Ilnytskyy, Yaroslav, John B. McIntyre, Adrijana D’Silva, et al.. (2023). Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer. Cancer Genomics & Proteomics. 20(5). 417–432. 1 indexed citations
3.
Rudin, Charles M., Martin Reck, Melissa L. Johnson, et al.. (2023). Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer. Journal of Hematology & Oncology. 16(1). 66–66. 89 indexed citations breakdown →
4.
Culos‐Reed, S. Nicole, Amane Abdul‐Razzak, Julia T. Daun, et al.. (2021). Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer. BMC Cancer. 21(1). 159–159. 32 indexed citations
5.
Bebb, Gwyn, et al.. (2018). P1.12-11 2010 – 2015 Extensive Stage SCLC Diagnoses in a Canadian Institution: Baseline Characteristics That Impact on the Overall Survival. Journal of Thoracic Oncology. 13(10). S577–S577. 1 indexed citations
6.
D’Silva, Adrijana, Gwyn Bebb, Terry Boyle, Steven T. Johnson, & Jeff K. Vallance. (2017). Demographic and clinical correlates of accelerometer assessed physical activity and sedentary time in lung cancer survivors. Psycho-Oncology. 27(3). 1042–1049. 16 indexed citations
7.
Feng, Xiaolan, Haocheng Li, Michelle L. Dean, et al.. (2015). Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer. Breast Cancer Research. 17(1). 65–65. 32 indexed citations
8.
Bebb, Gwyn, et al.. (2010). The emerging role of nimotuzumab in the treatment of non-small cell lung cancer. SHILAP Revista de lepidopterología. 9 indexed citations
10.
Alain, Tommy, Huong Muzik, Salina Chan, et al.. (2009). Susceptibility of mantle cell lymphomas to reovirus oncolysis. Leukemia Research. 34(1). 100–108. 5 indexed citations
11.
Bebb, Gwyn, et al.. (2008). The CXCR4/SDF-1 Chemokine Receptor Axis: A New Target Therapeutic for Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(12). 1379–1383. 55 indexed citations
13.
Pugh, Trevor J., Gwyn Bebb, Lorena Barclay, et al.. (2007). Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients. BMC Cancer. 7(1). 128–128. 30 indexed citations
14.
Bebb, Gwyn, Richard Klasa, Mukesh Chhanabhai, et al.. (2005). Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma. Leukemia Research. 30(4). 449–457. 27 indexed citations
15.
Gout, Peter W., Jun Guan, Yuwei Wang, et al.. (2004). Potential use for sulfasalazine in lung cancer therapy. Cancer Research. 64. 887–887. 1 indexed citations
16.
deLeeuw, Ronald J., Jonathan Davies, Gwyn Bebb, et al.. (2004). Identification of novel regions of genomic copy number alteration in mantle cell lymphoma by array comparative genomic hybridization to a 97,299 element whole genome DNA array. Cancer Research. 64. 391–391. 1 indexed citations
17.
Spacey, Sian, R A Gatti, & Gwyn Bebb. (2000). The Molecular Basis and Clinical Management of Ataxia Telangiectasia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 27(3). 184–191. 23 indexed citations
18.
Bebb, Gwyn, Barry W. Glickman, Karen A. Gelmon, & Richard A. Gatti. (1997). “AT risk” for breast cancer. The Lancet. 349(9068). 1784–1785. 15 indexed citations
19.
Curry, John, et al.. (1997). Similar mutant frequencies observed between pairs of monozygotic twins. Human Mutation. 9(5). 445–451. 9 indexed citations
20.
Clark, Susan J., et al.. (1992). Age and Blood Pressure Measurement: Experience with the TM2420 Ambulatory Blood Pressure Monitor and Elderly People. Age and Ageing. 21(6). 398–403. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026